ArticleOncotarget2019
Bevacizumab as maintenance therapy in mCRC: Interpreting results of the MOMA trial.
Federica Marmorino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleOncotarget2019
Federica Marmorino et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.